New York State Contract Reporter #2138461

Single Source Procurement of Trikafta Medication for Cystic Fibrosis Treatment

This procurement opportunity is for the specialty medication Trikafta to treat cystic fibrosis in an at-risk youth in custody, managed by the New York State Office of Children & Family Services, Bureau of Contract Management. - Government Buyer: - New York State Office of Children & Family Services - Bureau of Contract Management - OEM Highlight: - Vertex Pharmaceuticals Incorporated (manufacturer of Trikafta) - Vendor: - Caremark LLC (specialty pharmacy filling the prescription) - Products/Services Requested: - Trikafta (specialty medication for cystic fibrosis) - Quantity: 1 lot (for one patient) - Must be filled by a specialty pharmacy - Unique/Notable Requirements: - Single source exemption due to the specialty nature of the medication - Medication specifically required for the genetic mutation causing cystic fibrosis - Intended for an at-risk youth in state custody - Contract term is 9 months - No other OEMs or vendors are mentioned.

Description

The New York State Office of Children & Family Services requires the medication Trikafta to treat cystic fibrosis in an at-risk youth in custody. Trikafta addresses the mutation causing cystic fibrosis, improving symptoms and slowing disease progression. It is a specialty medication that must be dispensed by a specialty pharmacy. The contract term is 9 months and the procurement is a single source exemption.

View original listing